Search

Your search keyword '"Al-Attar N"' showing total 239 results
Start Over Author "Al-Attar N"
239 results on '"Al-Attar N"'

10. Wide-field surface-enhanced Raman scattering from ferroelectrically defined Au nanoparticle microarrays for optical sensing

Author

Al-attar, N., Al-Shammari, R. M., Manzo, Michele, Gallo, Katia, Rodriguez, B. J., Rice, J. H., Al-attar, N., Al-Shammari, R. M., Manzo, Michele, Gallo, Katia, Rodriguez, B. J., and Rice, J. H.

Abstract

The acquisition-time in optical sensors using SERS is vital value. Wide-field SERS is used to perform high-density of hot-spots of GNPs photodeposition on a periodically-protonexchanged- LiNbO3 which, leads to increase the sensitivity at ultralow probe concentrations., QC 20181022

Published
2018
Full Text
View/download PDF

11. Artículo especial Guía ESC 2015 sobre el diagnóstico y tratamiento de las enfermedades del pericardio: Grupo de Trabajo de la Sociedad Europea de Cardiología (ESC) para el diagnóstico y tratamiento de las enfermedades del pericardio

Author

Adler, Y, Charron, P, Imazio, M, Badano, L, Baron-Esquivias, G, Bogaert, J, Brucato, A, Gueret, P, Klingel, K, Lionis, C, Maisch, B, Mayosi, B, Pavie, A, Ristic, A, Tenas, M, Seferovic, P, Swedberg, K, Tomkowski, W, Achenbach, S, Agewall, S, Al-Attar, N, Ferrer, J, Arad, M, Asteggiano, R, Bueno, H, Caforio, A, Carerj, S, Ceconi, C, Evangelista, A, Flachskampf, F, Giannakoulas, G, Gielen, S, Habib, G, Kolh, P, Lambrinou, E, Lancellotti, P, Lazaros, G, Linhart, A, Meurin, P, Nieman, K, Piepoli, M, Price, S, Roos-Hesselink, J, Roubille, F, Ruschitzka, F, Sauleda, J, Sousa-Uvaa, M, Voigt, J, Zamorano, J, Adler Y., Charron P., Imazio M., Badano L., Baron-Esquivias G., Bogaert J., Brucato A., Gueret P., Klingel K., Lionis C., Maisch B., Mayosi B., Pavie A., Ristic A. D., Tenas M. S., Seferovic P., Swedberg K., Tomkowski W., Achenbach S., Agewall S., Al-Attar N., Ferrer J. A., Arad M., Asteggiano R., Bueno H., Caforio A. L. P., Carerj S., Ceconi C., Evangelista A., Flachskampf F., Giannakoulas G., Gielen S., Habib G., Kolh P., Lambrinou E., Lancellotti P., Lazaros G., Linhart A., Meurin P., Nieman K., Piepoli M. F., Price S., Roos-Hesselink J., Roubille F., Ruschitzka F., Sauleda J. S., Sousa-Uvaa M., Voigt J. U., Zamorano J. L., Adler, Y, Charron, P, Imazio, M, Badano, L, Baron-Esquivias, G, Bogaert, J, Brucato, A, Gueret, P, Klingel, K, Lionis, C, Maisch, B, Mayosi, B, Pavie, A, Ristic, A, Tenas, M, Seferovic, P, Swedberg, K, Tomkowski, W, Achenbach, S, Agewall, S, Al-Attar, N, Ferrer, J, Arad, M, Asteggiano, R, Bueno, H, Caforio, A, Carerj, S, Ceconi, C, Evangelista, A, Flachskampf, F, Giannakoulas, G, Gielen, S, Habib, G, Kolh, P, Lambrinou, E, Lancellotti, P, Lazaros, G, Linhart, A, Meurin, P, Nieman, K, Piepoli, M, Price, S, Roos-Hesselink, J, Roubille, F, Ruschitzka, F, Sauleda, J, Sousa-Uvaa, M, Voigt, J, Zamorano, J, Adler Y., Charron P., Imazio M., Badano L., Baron-Esquivias G., Bogaert J., Brucato A., Gueret P., Klingel K., Lionis C., Maisch B., Mayosi B., Pavie A., Ristic A. D., Tenas M. S., Seferovic P., Swedberg K., Tomkowski W., Achenbach S., Agewall S., Al-Attar N., Ferrer J. A., Arad M., Asteggiano R., Bueno H., Caforio A. L. P., Carerj S., Ceconi C., Evangelista A., Flachskampf F., Giannakoulas G., Gielen S., Habib G., Kolh P., Lambrinou E., Lancellotti P., Lazaros G., Linhart A., Meurin P., Nieman K., Piepoli M. F., Price S., Roos-Hesselink J., Roubille F., Ruschitzka F., Sauleda J. S., Sousa-Uvaa M., Voigt J. U., and Zamorano J. L.

Published
2015

12. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases

Author

Adler, Y, Charron, P, Imazio, M, Badano, L, Baron-Esquivias, G, Bogaert, J, Brucato, A, Gueret, P, Klingel, K, Lionis, C, Maisch, B, Mayosi, B, Pavie, A, Ristic, A, Tenas, M, Seferovic, P, Swedberg, K, Tomkowski, W, Achenbach, S, Agewall, S, Al-Attar, N, Ferrer, J, Arad, M, Asteggiano, R, Bueno, H, Caforio, A, Carerj, S, Ceconi, C, Evangelista, A, Flachskampf, F, Giannakoulas, G, Gielen, S, Habib, G, Kolh, P, Lambrinou, E, Lancellotti, P, Lazaros, G, Linhart, A, Meurin, P, Nieman, K, Piepoli, M, Price, S, Roos-Hesselink, J, Zamorano, J, Aboyans, V, Badimon, L, Baumgartner, H, Bax, J, Dean, V, Erol, C, Fitzimons, D, Gaemperli, O, Kirchhof, P, Lip, G, Nihoyannopoulos, P, Ponikowski, P, Roffi, M, Torbicki, A, Carneiro, A, Windecker, S, Adler Y., Charron P., Imazio M., Badano L., Baron-Esquivias G., Bogaert J., Brucato A., Gueret P., Klingel K., Lionis C., Maisch B., Mayosi B., Pavie A., Ristic A. D., Tenas M. S., Seferovic P., Swedberg K., Tomkowski W., Achenbach S., Agewall S., Al-Attar N., Ferrer J. A., Arad M., Asteggiano R., Bueno H., Caforio A. L. P., Carerj S., Ceconi C., Evangelista A., Flachskampf F., Giannakoulas G., Gielen S., Habib G., Kolh P., Lambrinou E., Lancellotti P., Lazaros G., Linhart A., Meurin P., Nieman K., Piepoli M. F., Price S., Roos-Hesselink J., Zamorano J. L., Aboyans V., Badimon L., Baumgartner H., Bax J. J., Dean V., Erol C., Fitzimons D., Gaemperli O., Kirchhof P., Lip G. Y. H., Nihoyannopoulos P., Ponikowski P., Roffi M., Torbicki A., Carneiro A. V., Windecker S., Adler, Y, Charron, P, Imazio, M, Badano, L, Baron-Esquivias, G, Bogaert, J, Brucato, A, Gueret, P, Klingel, K, Lionis, C, Maisch, B, Mayosi, B, Pavie, A, Ristic, A, Tenas, M, Seferovic, P, Swedberg, K, Tomkowski, W, Achenbach, S, Agewall, S, Al-Attar, N, Ferrer, J, Arad, M, Asteggiano, R, Bueno, H, Caforio, A, Carerj, S, Ceconi, C, Evangelista, A, Flachskampf, F, Giannakoulas, G, Gielen, S, Habib, G, Kolh, P, Lambrinou, E, Lancellotti, P, Lazaros, G, Linhart, A, Meurin, P, Nieman, K, Piepoli, M, Price, S, Roos-Hesselink, J, Zamorano, J, Aboyans, V, Badimon, L, Baumgartner, H, Bax, J, Dean, V, Erol, C, Fitzimons, D, Gaemperli, O, Kirchhof, P, Lip, G, Nihoyannopoulos, P, Ponikowski, P, Roffi, M, Torbicki, A, Carneiro, A, Windecker, S, Adler Y., Charron P., Imazio M., Badano L., Baron-Esquivias G., Bogaert J., Brucato A., Gueret P., Klingel K., Lionis C., Maisch B., Mayosi B., Pavie A., Ristic A. D., Tenas M. S., Seferovic P., Swedberg K., Tomkowski W., Achenbach S., Agewall S., Al-Attar N., Ferrer J. A., Arad M., Asteggiano R., Bueno H., Caforio A. L. P., Carerj S., Ceconi C., Evangelista A., Flachskampf F., Giannakoulas G., Gielen S., Habib G., Kolh P., Lambrinou E., Lancellotti P., Lazaros G., Linhart A., Meurin P., Nieman K., Piepoli M. F., Price S., Roos-Hesselink J., Zamorano J. L., Aboyans V., Badimon L., Baumgartner H., Bax J. J., Dean V., Erol C., Fitzimons D., Gaemperli O., Kirchhof P., Lip G. Y. H., Nihoyannopoulos P., Ponikowski P., Roffi M., Torbicki A., Carneiro A. V., and Windecker S.

Published
2015

13. Guidelines for the management of atrial fibrillation The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

Author

Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas PE, Widimsky P, Agladze V, Aliot E, Balabanski T, Blomstrom Lundqvist C, Capucci A, Crijns H, Dahlöf B, Folliguet T, Glikson M, Goethals M, Gulba DC, Ho SY, Klautz RJ, Kose S, McMurray J, PERRONE FILARDI, PASQUALE, Raatikainen P, Salvador MJ, Schalij MJ, Shpektor A, Sousa J, Stepinska J, Uuetoa H, Zamorano JL, Zupan I, European Heart Rhythm Association, European Association for Cardio Thoracic Surgery, ESC Committee for Practice Guidelines, Document Reviewers, Camm, Aj, Kirchhof, P, Lip, Gy, Schotten, U, Savelieva, I, Ernst, S, Van Gelder, Ic, Al Attar, N, Hindricks, G, Prendergast, B, Heidbuchel, H, Alfieri, O, Angelini, A, Atar, D, Colonna, P, De Caterina, R, De Sutter, J, Goette, A, Gorenek, B, Heldal, M, Hohloser, Sh, Kolh, P, Le Heuzey, Jy, Ponikowski, P, Rutten, Fh, Vahanian, A, Auricchio, A, Bax, J, Ceconi, C, Dean, V, Filippatos, G, Funck Brentano, C, Hobbs, R, Kearney, P, Mcdonagh, T, Popescu, Ba, Reiner, Z, Sechtem, U, Sirnes, Pa, Tendera, M, Vardas, Pe, Widimsky, P, Agladze, V, Aliot, E, Balabanski, T, Blomstrom Lundqvist, C, Capucci, A, Crijns, H, Dahlöf, B, Folliguet, T, Glikson, M, Goethals, M, Gulba, Dc, Ho, Sy, Klautz, Rj, Kose, S, Mcmurray, J, PERRONE FILARDI, Pasquale, Raatikainen, P, Salvador, Mj, Schalij, Mj, Shpektor, A, Sousa, J, Stepinska, J, Uuetoa, H, Zamorano, Jl, Zupan, I, European Heart Rhythm, Association, European Association for Cardio Thoracic, Surgery, ESC Committee for Practice, Guideline, Document, Reviewers, Alfieri, Ottavio, Ponikowski, P., Fysiologie, Cardiologie, RS: CARIM School for Cardiovascular Diseases, Camm, A. J, Lip, G, Van Gelder, I. C, Hohloser, S. H, and Le Heuzey, J. Y.

Subjects
Lung Diseases, Male, Rate control, Heart Valve Diseases, Management of atrial fibrillation, Angiotensin-Converting Enzyme Inhibitors, Comorbidity, Upstream therapy, Hyperthyroidism, law.invention, Cardiac Resynchronization Therapy, Electrocardiography, Ventricular Dysfunction, Left, Postoperative Complications, Atrial fibrillation European Society of Cardiology Guidelines Anticoagulation Rate control Rhythm control Upstream therapy Pulmonary vein isolation Left atrial ablation randomized controlled-trial congestive-heart-failure parkinson-white-syndrome cardiac resynchronization therapy angiotensin-converting enzyme polyunsaturated fatty-acids antiarrhythmic-drug therapy long-term survival radiofrequency catheter ablation placebo-controlled trial, Randomized controlled trial, Heart Rate, Pregnancy, Recurrence, law, Prevalence, Secondary Prevention, Medicine, Angioplasty, Balloon, Coronary, Precision Medicine, Mineralocorticoid Receptor Antagonists, Middle Aged, Congestive-Heart-Failure, Left atrial ablation, Primary Prevention, Stroke, Catheter Ablation, Cardiology, Female, Rhythm control, Cardiology and Cardiovascular Medicine, Risk assessment, Anti-Arrhythmia Agents, Sports, Radiofrequency Catheter Ablation, Adult, medicine.medical_specialty, Point-of-Care Systems, Angiotensin-Converting Enzyme, Antiarrhythmic-Drug Therapy, Placebo-Controlled Trial, Electric Countershock, MEDLINE, Hemorrhage, Guidelines, Parkinson-White-Syndrome, Risk Assessment, Pulmonary vein isolation, European Society of Cardiology, Anticoagulation, Fibrinolytic Agents, Thromboembolism, Internal medicine, Diabetes Mellitus, Humans, Polyunsaturated Fatty-Acids, International Normalized Ratio, Acute Coronary Syndrome, Randomized Controlled-Trial, Long-Term Survival, Aged, Heart Failure, Intraoperative Care, business.industry, Conflict of interest, Anticoagulants, Evidence-based medicine, Cardiomyopathy, Hypertrophic, Precision medicine, Atrial fibrillation, Athletes, CHA2DS2–VASc score, Quality of Life, Wolff-Parkinson-White Syndrome, Hydroxymethylglutaryl-CoA Reductase Inhibitors, business, Platelet Aggregation Inhibitors
Abstract

Guidelines summarize and evaluate all currently available evidence on a particular issue with the aim of assisting physicians in selecting the best management strategy for an individual patient suffering from a given condition, taking into account the impact on outcome, as well as the risk–benefit ratio of particular diagnostic or therapeutic means. Guidelines are no substitutes for textbooks. The legal implications of medical guidelines have been discussed previously. A large number of Guidelines have been issued in recent years by the European Society of Cardiology (ESC) as well as by other societies and organizations. Because of the impact on clinical practice, quality criteria for development of guidelines have been established in order to make all decisions transparent to the user. The recommendations for formulating and issuing ESC Guidelines can be found on the ESC Web Site (http://www.escardio.org/guidelines-surveys/esc-guidelines/about/Pages/rules-writing.aspx). In brief, experts in the field are selected and undertake a comprehensive review of the published evidence for management and/or prevention of a given condition. A critical evaluation of diagnostic and therapeutic procedures is performed, including assessment of the risk–benefit ratio. Estimates of expected health outcomes for larger societies are included, where data exist. The level of evidence and the strength of recommendation of particular treatment options are weighed and graded according to pre-defined scales, as outlined in Tables 1 and 2 . View this table: Table 1 Classes of recommendations View this table: Table 2 Levels of evidence The experts of the writing panels have provided disclosure statements of all relationships they may have that might be perceived as real or potential sources of conflicts of interest. These disclosure forms are kept on file at the European Heart House, headquarters of the ESC. Any changes in conflict of interest that arise during the writing period must be notified to the ESC. The Task Force report received its entire financial support from …

Published
2010

14. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS)

Author

Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, Brucato A, Gueret P, Klingel K, Lionis C, Maisch B, Mayosi B, Pavie A, Ristic AD, Sabaté Tenas M, Seferovic P, Swedberg K, Tomkowski W, Achenbach S, Agewall S, Al-Attar N, Angel Ferrer J, Arad M, Asteggiano R, Bueno H, Caforio ALP, Carerj S, Ceconi C, Evangelista A, Flachskampf F, Giannakoulas G, Gielen S, Habib G, Kolh P, Lambrinou E, Lancellotti P, Lazaros G, Linhart A, Meurin P, Nieman K, Piepoli MF, Price S, Roos-Hesselink J, Roubille F, Ruschitzka F, Sagristà Sauleda J, Sousa-Uva M, Uwe Voigt J, Luis Zamorano J, Zamorano JL, Aboyans V, Badimon L, Baumgartner H, Bax JJ, Dean V, Erol Ç, Fitzimons D, Gaemperli O, Kirchhof P, Lip GY, Nihoyannopoulos P, Ponikowski P, Roffi M, Torbicki A, Vaz Carneiro A, Windecker S, Shuka N, Sisakian H, Mascherbauer J, Isayev E, Shumavets V, Van Camp G, Gatzov P, Hanzevacki JS, Moustra HH, Møller JE, Aboleineen MW, Põder P, Lehtonen J, Antov S, Damy T, Schieffer B, Dimitriadis K, Kiss RG, Rafnsson A, Novo S, Mirrakhimov E, Stradinš P, Kavoliuniene A, Codreanu A, Dingli P, Vataman E, El Hattaoui M, Samstad SO, Hoffman P, Lopes LR, Dimulescu DR, Arutyunov GP, Pavlovic M, Dúbrava J, Sauleda JS, Andersson B, Müller H, Bouma BJ, Abaci A, Archbold A, Nesukay E, and Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, Brucato A, Gueret P, Klingel K, Lionis C, Maisch B, Mayosi B, Pavie A, Ristic AD, Sabaté Tenas M, Seferovic P, Swedberg K, Tomkowski W, Achenbach S, Agewall S, Al-Attar N, Angel Ferrer J, Arad M, Asteggiano R, Bueno H, Caforio ALP, Carerj S, Ceconi C, Evangelista A, Flachskampf F, Giannakoulas G, Gielen S, Habib G, Kolh P, Lambrinou E, Lancellotti P, Lazaros G, Linhart A, Meurin P, Nieman K, Piepoli MF, Price S, Roos-Hesselink J, Roubille F, Ruschitzka F, Sagristà Sauleda J, Sousa-Uva M, Uwe Voigt J, Luis Zamorano J, Zamorano JL, Aboyans V, Achenbach S, Agewall S, Badimon L, Barón-Esquivias G, Baumgartner H, Bax JJ, Bueno H, Carerj S, Dean V, Erol Ç, Fitzimons D, Gaemperli O, Kirchhof P, Kolh P, Lancellotti P, Lip GY, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Roffi M, Torbicki A, Vaz Carneiro A, Windecker S, Shuka N, Sisakian H, Mascherbauer J, Isayev E, Shumavets V, Van Camp G, Gatzov P, Hanzevacki JS, Moustra HH, Linhart A, Møller JE, Aboleineen MW, Põder P, Lehtonen J, Antov S, Damy T, Schieffer B, Dimitriadis K, Kiss RG, Rafnsson A, Arad M, Novo S, Mirrakhimov E, Stradinš P, Kavoliuniene A, Codreanu A, Dingli P, Vataman E, El Hattaoui M, Samstad SO, Hoffman P, Lopes LR, Dimulescu DR, Arutyunov GP, Pavlovic M, Dúbrava J, Sauleda JS, Andersson B, Müller H, Bouma BJ, Abaci A, Archbold A, Nesukay E

Subjects
Pericardiocentesi, Prognosi, Myopericarditi, Tamponade, Constrictive pericarditi, Pericardial effusion, Pericarditi, Therapy, Aetiology, Guideline, Pericardium, Diagnosi
Abstract

Guidelines summarize and evaluate all available evidence on a particular issue at the time of the writing process, with the aim of assisting health professionals in selecting the best management strategies for an individual patient with a given condition, taking into account the impact on outcome, as well as the risk–benefit ratio of particular diagnostic or therapeutic means. Guidelines and recommendations should help health professionals to make decisions in their daily practice. However, the final decisions concerning an individual patient must be made by the responsible health professional(s) in consultation with the patient and caregiver as appropriate.

Published
2015

18. Patient Survival and Therapeutic Outcomes in the UK Bridge to Heart Transplant Ventricular Assist Device Population

Author

Rushton, S., primary, Hogg, R., additional, Banner, N., additional, Simon, A., additional, Venkateswaran, R., additional, Shaw, S., additional, Al-Attar, N., additional, Dalzell, J., additional, Schueler, S., additional, MacGowan, G., additional, Mascaro, J., additional, Sern, L., additional, Tsui, S., additional, and Parameshwar, J., additional

Published
2018
Full Text
View/download PDF

22. LVADs as Bridge to Candidacy in the UK

Author

Shaw, S.M., primary, Venkateswaran, R., additional, Rushton, S.N., additional, Hogg, R., additional, Al-Attar, N., additional, Lim, S., additional, Schueler, S., additional, Parameshwar, J., additional, and Banner, N., additional

Published
2018
Full Text
View/download PDF

24. The flaws in the detail of an observational study on transcatheter aortic valve implantation versus surgical aortic valve replacement in intermediate-risks patients

Author

Barili, F. (Fabio), Freemantle, N. (Nick), Folliguet, T. (Thierry), Muneretto, C. (Claudio), Bonis, M. (MicheleDe), Czerny, M. (Martin), Obadia, J.F. (Jean Francois), Al-Attar, N. (Nawwar), Bonaros, N. (Nikolaos), Kluin, J. (Jolanda), Lorusso, R. (Roberto), Punjabi, P. (Prakash), Sadaba, R. (Rafael), Suwalski, P. (Piotr), Benedetto, U. (Umberto), Böning, A. (Andreas), Falk, V. (Volkmar), Sousa-Uva, M. (Miguel), Kappetein, A.P. (Arie Pieter), Menicanti, L. (Lorenzo), Barili, F. (Fabio), Freemantle, N. (Nick), Folliguet, T. (Thierry), Muneretto, C. (Claudio), Bonis, M. (MicheleDe), Czerny, M. (Martin), Obadia, J.F. (Jean Francois), Al-Attar, N. (Nawwar), Bonaros, N. (Nikolaos), Kluin, J. (Jolanda), Lorusso, R. (Roberto), Punjabi, P. (Prakash), Sadaba, R. (Rafael), Suwalski, P. (Piotr), Benedetto, U. (Umberto), Böning, A. (Andreas), Falk, V. (Volkmar), Sousa-Uva, M. (Miguel), Kappetein, A.P. (Arie Pieter), and Menicanti, L. (Lorenzo)

Abstract

The PARTNER group recently published a comparison between the latest generation SAPIEN 3 transcatheter aortic valve implantation (TAVI) system (Edwards Lifesciences, Irvine, CA, USA) and surgical aortic valve replacement (SAVR) in intermediate-risk patients, apparently demonstrating superiority of the TAVI and suggesting that TAVI might be the preferred treatment method in this risk class of patients. Nonetheless, assessment of the non-randomized methodology used in this comparison reveals challenges that should be addressed in order to elucidate the validity of the results. The study by Thourani and colleagues showed several major methodological concerns: suboptimal methods in propensity score analysis with evident misspecification of the propensity scores (PS; no adjustment for the most significantly different covariates: left ventricular ejection fraction, moderate-severe mitral regurgitation and associated procedures); use of PS quintiles rather than matching; inference on not-adjusted Kaplan-Meier curves, although the authors correctly claimed for the need of balancing score adjusting for confounding factors in order to have unbiased estimates of the treatment effect; evidence of poor fit; lack of data on valve-related death. These methodological flaws invalidate direct comparison between treatments and cannot support authors' conclusions that TAVI with SAPIEN 3 in intermediate-risk patients is superior to surgery and might be the preferred treatment alternative to surgery.

Published
2017
Full Text
View/download PDF

25. ESC Joint Working Groups on Cardiovascular Surgery and the Cellular Biology of the Heart Position Paper: Peri-operativemyocardial injury and infarction in patients undergoing coronary artery bypass graft surgery

Author

Thielmann, M. (Matthias), Sharma, V. (Vikram), Al-Attar, N. (Nawwar), Bulluck, H. (Heerajnarain), Bisleri, G. (Gianluigi), Bunge, J.J.H. (Jeroen), Czerny, M. (Martin), Ferdinandy, P. (Peter), Frey, U.H. (Ulrich H.), Heusch, G. (Gerd), Holfeld, J. (Johannes), Kleinbongard, P. (Petra), Kunst, G. (Gudrun), Lang, I. (Irene), Lentini, S. (Salvatore), Madonna, R. (Rosalinda), Meybohm, P. (Patrick), Muneretto, C. (Claudio), Obadia, J.-F. (Jean-Francois), Perrino, C. (Cinzia), Prunier, F. (Fabrice), Sluijter, J.P.G. (Joost P.G.), Van Laake, L.W. (Linda W.), Sousa-Uva, M. (Miguel), Hausenloy, D.J. (Derek J.), Thielmann, M. (Matthias), Sharma, V. (Vikram), Al-Attar, N. (Nawwar), Bulluck, H. (Heerajnarain), Bisleri, G. (Gianluigi), Bunge, J.J.H. (Jeroen), Czerny, M. (Martin), Ferdinandy, P. (Peter), Frey, U.H. (Ulrich H.), Heusch, G. (Gerd), Holfeld, J. (Johannes), Kleinbongard, P. (Petra), Kunst, G. (Gudrun), Lang, I. (Irene), Lentini, S. (Salvatore), Madonna, R. (Rosalinda), Meybohm, P. (Patrick), Muneretto, C. (Claudio), Obadia, J.-F. (Jean-Francois), Perrino, C. (Cinzia), Prunier, F. (Fabrice), Sluijter, J.P.G. (Joost P.G.), Van Laake, L.W. (Linda W.), Sousa-Uva, M. (Miguel), and Hausenloy, D.J. (Derek J.)

Published
2017
Full Text
View/download PDF

26. ESC Joint Working Groups on Cardiovascular Surgery and the Cellular Biology of the Heart Position Paper: Peri-operative myocardial injury and infarction in patients undergoing coronary artery bypass graft surgery

Author

Thielmann, M, Sharma, V, Al-Attar, N, Bulluck, H, Bisleri, G, Bunge, Jeroen, Czerny, M, Ferdinandy, P, Frey, UH, Heusch, G, Holfeld, J, Kleinbongard, P, Kunst, G, Lang, I, Lentini, S, Madonna, R, Meybohm, P, Muneretto, C, Obadia, JF, Perrino, C, Prunier, F, Sluijter, JPG, Van Laake, L, Sousa-Uva, M, Hausenloy, DJ, Thielmann, M, Sharma, V, Al-Attar, N, Bulluck, H, Bisleri, G, Bunge, Jeroen, Czerny, M, Ferdinandy, P, Frey, UH, Heusch, G, Holfeld, J, Kleinbongard, P, Kunst, G, Lang, I, Lentini, S, Madonna, R, Meybohm, P, Muneretto, C, Obadia, JF, Perrino, C, Prunier, F, Sluijter, JPG, Van Laake, L, Sousa-Uva, M, and Hausenloy, DJ

Published
2017

27. The flaws in the detail of an observational study on transcatheter aortic valve implantation versus surgical aortic valve replacement in intermediate-risks patients

Author

Barili, F, Freemantle, N, Folliguet, T, Muneretto, C, De Bonis, M, Czerny, M, Obadia, JF, Al-Attar, N, Bonaros, N, Kluin, J, Lorusso, R, Punjabi, P, Sadaba, R, Suwalskin, P, Benedetto, U, Boning, A, Falk, V, Sousa-Uva, M, Kappetein, Arie-Pieter, Menicanti, L, Barili, F, Freemantle, N, Folliguet, T, Muneretto, C, De Bonis, M, Czerny, M, Obadia, JF, Al-Attar, N, Bonaros, N, Kluin, J, Lorusso, R, Punjabi, P, Sadaba, R, Suwalskin, P, Benedetto, U, Boning, A, Falk, V, Sousa-Uva, M, Kappetein, Arie-Pieter, and Menicanti, L

Published
2017

30. 2012 Focused Update of the ESC Guidelines for the Management of Atrial Fibrillation [Actualización detallada de las guías de la ESC para el manejo de la fibrilación auricular de 2012]

Author

Camm AJ, Lip GYH, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck Brentano C, Hasdai D, Hoes A, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Vardas P, Al Attar N, ALFIERI , OTTAVIO, Angelini A, Blomstrom Lundqvist C, Colonna P, De Sutter J, Ernst S, Goette A, Gorenek B, Hatala R, Heidbuchel H, Heldal M, Kristensen SD, Le Heuzey JY, Mavrakis H, Mont L, Filardi PP, Ponikowski P, Prendergast B, Rutten FH, Schotten U, Van Gelder IC, Verheugt FWA, Camm, Aj, Lip, Gyh, De Caterina, R, Savelieva, I, Atar, D, Hohnloser, Sh, Hindricks, G, Kirchhof, P, Bax, Jj, Baumgartner, H, Ceconi, C, Dean, V, Deaton, C, Fagard, R, Funck Brentano, C, Hasdai, D, Hoes, A, Knuuti, J, Kolh, P, Mcdonagh, T, Moulin, C, Popescu, Ba, Reiner, Z, Sechtem, U, Sirnes, Pa, Tendera, M, Torbicki, A, Vahanian, A, Windecker, S, Vardas, P, Al Attar, N, Alfieri, Ottavio, Angelini, A, Blomstrom Lundqvist, C, Colonna, P, De Sutter, J, Ernst, S, Goette, A, Gorenek, B, Hatala, R, Heidbuchel, H, Heldal, M, Kristensen, Sd, Le Heuzey, Jy, Mavrakis, H, Mont, L, Filardi, Pp, Ponikowski, P, Prendergast, B, Rutten, Fh, Schotten, U, Van Gelder, Ic, and Verheugt, Fwa

Published
2013

31. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

Author

Camm, Aj, Lip, Gy, De Caterina, R, Savelieva, I, Atar, D, Hohnloser, Sh, Hindricks, G, Kirchhof, P, Bax, Jj, Baumgartner, H, Ceconi, C, Dean, V, Deaton, C, Fagard, R, Funck Brentano, C, Hasdai, D, Hoes, A, Knuuti, J, Kolh, P, Mcdonagh, T, Moulin, C, Popescu, Ba, Reiner, Z, Sechtem, U, Sirnes, Pa, Tendera, M, Torbicki, A, Vahanian, A, Windecker, S, Vardas, P, Al Attar, N, Alfieri, O, Angelini, Annalisa, Blömstrom Lundqvist, C, Colonna, P, De Sutter, J, Ernst, S, Goette, A, Gorenek, B, Hatala, R, Heidbüchel, H, Heldal, M, Kristensen, Sd, Le Heuzey JY, Mavrakis, H, Mont, L, Filardi, Pp, Ponikowski, P, Prendergast, B, Rutten, Fh, Schotten, U, Van Gelder IC, Verheugt, Fw, Authors/Task Force Members, ESC Committee for Practice Guidelines, Document, Reviewers, Authors/Task Force, Member, Camm, Aj, Lip, Gy, De Caterina, R, Savelieva, I, Atar, D, Hohnloser, Sh, Hindricks, G, Kirchhof, P, ESC Committee for Practice, Guideline, Bax, Jj, Baumgartner, H, Ceconi, C, Dean, V, Deaton, C, Fagard, R, Funck Brentano, C, Hasdai, D, Hoes, A, Knuuti, J, Kolh, P, Mcdonagh, T, Moulin, C, Popescu, Ba, Reiner, Z, Sechtem, U, Sirnes, Pa, Tendera, M, Torbicki, A, Vahanian, A, Windecker, S, Document, Reviewer, Vardas, P, Al Attar, N, Alfieri, Ottavio, Angelini, A, Bl√∂mstrom Lundqvist, C, Colonna, P, De Sutter, J, Ernst, S, Goette, A, Gorenek, B, Hatala, R, Heidb√ºchel, H, Heldal, M, Kristensen, Sd, Le Heuzey, Jy, Mavrakis, H, Mont, L, Filardi, Pp, Ponikowski, P, Prendergast, B, Rutten, Fh, Schotten, U, Van Gelder, Ic, and Verheugt, Fw

Subjects
Heart Failure, Electric Countershock, Anticoagulants, Hemorrhage, atrial fibrillation, guidelines, Risk Assessment, Stroke, Early Diagnosis, Thromboembolism, Atrial Fibrillation, Catheter Ablation, Humans, Atrial Appendage, Therapeutic Occlusion, Anti-Arrhythmia Agents
Published
2012

32. Guidelines for the management of atrial fibrillation (vol 12, pg 1360, 2010)

Author

Camm AJ, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al Attar N, Hindricks G, Prendergast B, Heidbuchel H, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH, ALFIERI , OTTAVIO, Camm, Aj, Kirchhof, P, Lip, Gyh, Schotten, U, Savelieva, I, Ernst, S, Van Gelder, Ic, Al Attar, N, Hindricks, G, Prendergast, B, Heidbuchel, H, Alfieri, Ottavio, Angelini, A, Atar, D, Colonna, P, De Caterina, R, De Sutter, J, Goette, A, Gorenek, B, Heldal, M, Hohloser, Sh, Kolh, P, Le Heuzey, Jy, Ponikowski, P, and Rutten, Fh

Published
2011

33. ESC Guidelines on the management of cardiovascular diseases during pregnancy

Author

European Society of Gynecology, Association for European Paediatric Cardiology, German Society for Gender Medicine, Authors/Task Force Members, Regitz Zagrosek V., Blomstrom Lundqvist C., Cifkova R., Ferreira R., Foidart J. M., Gibbs J. S., Gohlke Baerwolf C., Gorenek B., Iung B., Kirby M., Maas A. H., Morais J., Nihoyannopoulos P., Pieper P. G., Presbitero P., Roos Hesselink J. W., Schaufelberger M., Seeland U., Torracca L, ESC Committee for Practice Guidelines, Bax J., Auricchio A., Baumgartner H., Ceconi C., Dean V., Deaton C., Fagard R., Funck Brentano C., Hasdai D., Hoes A., Knuuti J., Kolh P., McDonagh T., Moulin C., Poldermans D., Popescu B. A., Reiner Z., Sechtem U., Sirnes P. A., Torbicki A., Vahanian A., Windecker S., Document Reviewers, Aguiar C., Al Attar N., Garcia A. A., Antoniou A., Coman I., Elkayam U., Gomez Sanchez M. A., Gotcheva N., Hilfiker Kleiner D., Kiss R. G., Kitsiou A., Konings K. T., Lip G. Y., Manolis A., Mebaaza A., Mintale I., Morice M. C., Mulder B. J., Pasquet A., Price S., Priori S. G., Salvador M. J., Shotan A., Silversides C. K., Skouby S. O., Stein J. I., Tornos P., Vejlstrup N., Walker F., Warnes C., BORGHI, CLAUDIO, European Society of Gynecology, Association for European Paediatric Cardiology, German Society for Gender Medicine, Authors/Task Force Members, Regitz-Zagrosek V., Blomstrom Lundqvist C., Borghi C., Cifkova R., Ferreira R., Foidart J.M., Gibbs J.S., Gohlke-Baerwolf C., Gorenek B., Iung B., Kirby M., Maas A.H., Morais J., Nihoyannopoulos P., Pieper P.G., Presbitero P., Roos-Hesselink J.W., Schaufelberger M., Seeland U., Torracca L, ESC Committee for Practice Guidelines, Bax J., Auricchio A., Baumgartner H., Ceconi C., Dean V., Deaton C., Fagard R., Funck-Brentano C., Hasdai D., Hoes A., Knuuti J., Kolh P., McDonagh T., Moulin C., Poldermans D., Popescu B.A., Reiner Z., Sechtem U., Sirnes P.A., Torbicki A., Vahanian A., Windecker S., and Document Reviewers, Baumgartner H., Deaton C., Aguiar C., Al-Attar N., Garcia A.A., Antoniou A., Coman I., Elkayam U., Gomez-Sanchez M.A., Gotcheva N., Hilfiker-Kleiner D., Kiss R.G., Kitsiou A., Konings K.T., Lip G.Y., Manolis A., Mebaaza A., Mintale I., Morice M.C., Mulder B.J., Pasquet A., Price S., Priori S.G., Salvador M.J., Shotan A., Silversides C.K., Skouby S.O., Stein J.I., Tornos P., Vejlstrup N., Walker F., Warnes C.

Subjects
Counseling, Prenatal Diagnosi, Pregnancy Complications, Cardiovascular, Heart failure, Abortion, Induced, Prenatal Care, Venous Thromboembolism, Guideline, Cardiovascular disease, Aortic Disease, Valvular heart disease, Management, Congential heart disease, Heart Disease, Cardiovascular Agent, Pregnancy, Hypertension, Pregnancy Complications, Infectiou, Female, Cardiology and Cardiovascular Medicine, Arrhythmia, Risk assessment, Human
Abstract

not available

Published
2011

34. Guidelines for the diagnosis and treatment of pulmonary hypertension

Author

Task Force for Diagnosis, Treatment of Pulmonary Hypertension of European Society of Cardiology, European Respiratory Society, International Society of Heart, Lung Transplantation, Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck Brentano C, Hobbs R, Kearney P, McDonagh T, McGregor KH, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas P, Widimsky P, Al Attar N, Andreotti F, Aschermann M, Benza R, Berger R, Bonnet D, Delcroix M, Howard L, Kitsiou AN, Lang I, Nielsen Kudsk JE, Park M, Price S, Subirana MT, Vonk Noordegraaf A, Zamorano J.L., PERRONE FILARDI, PASQUALE, Task Force for, Diagnosi, Treatment of Pulmonary Hypertension of European Society of, Cardiology, European Respiratory, Society, International Society of, Heart, Lung, Transplantation, Galiè, N, Hoeper, Mm, Humbert, M, Torbicki, A, Vachiery, Jl, Barbera, Ja, Beghetti, M, Corris, P, Gaine, S, Gibbs, J, Gomez Sanchez, Ma, Jondeau, G, Klepetko, W, Opitz, C, Peacock, A, Rubin, L, Zellweger, M, Simonneau, G, Vahanian, A, Auricchio, A, Bax, J, Ceconi, C, Dean, V, Filippatos, G, Funck Brentano, C, Hobbs, R, Kearney, P, Mcdonagh, T, Mcgregor, Kh, Popescu, Ba, Reiner, Z, Sechtem, U, Sirnes, Pa, Tendera, M, Vardas, P, Widimsky, P, Al Attar, N, Andreotti, F, Aschermann, M, Benza, R, Berger, R, Bonnet, D, Delcroix, M, Howard, L, Kitsiou, An, Lang, I, Nielsen Kudsk, Je, Park, M, PERRONE FILARDI, Pasquale, Price, S, Subirana, Mt, Vonk Noordegraaf, A, and Zamorano, J. L.

Published
2009

35. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)

Author

Authors/Task Force Members, Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G, ESC Committee for Practice Guidelines, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck Brentano C, Hobbs R, Kearney P, McDonagh T, McGregor K, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas P, Widimsky P, Document Reviewers, Al Attar N, Andreotti F, Aschermann M, Asteggiano R, Benza R, Berger R, Bonnet D, Delcroix M, Howard L, Kitsiou AN, Lang I, Maggioni A, Nielsen Kudsk JE, Park M, Price S, Domenech MT, Vonk Noordegraaf A, Zamorano J.L., PERRONE FILARDI, PASQUALE, Authors/Task Force, Member, Galiè, N, Hoeper, Mm, Humbert, M, Torbicki, A, Vachiery, Jl, Barbera, Ja, Beghetti, M, Corris, P, Gaine, S, Gibbs, J, Gomez Sanchez, Ma, Jondeau, G, Klepetko, W, Opitz, C, Peacock, A, Rubin, L, Zellweger, M, Simonneau, G, ESC Committee for Practice, Guideline, Vahanian, A, Auricchio, A, Bax, J, Ceconi, C, Dean, V, Filippatos, G, Funck Brentano, C, Hobbs, R, Kearney, P, Mcdonagh, T, Mcgregor, K, Popescu, Ba, Reiner, Z, Sechtem, U, Sirnes, Pa, Tendera, M, Vardas, P, Widimsky, P, Document, Reviewer, Al Attar, N, Andreotti, F, Aschermann, M, Asteggiano, R, Benza, R, Berger, R, Bonnet, D, Delcroix, M, Howard, L, Kitsiou, An, Lang, I, Maggioni, A, Nielsen Kudsk, Je, Park, M, PERRONE FILARDI, Pasquale, Price, S, Domenech, Mt, Vonk Noordegraaf, A, Zamorano, J. L., Cardiovascular Centre (CVC), Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, and Simonneau G.

Subjects
medicine.medical_treatment, Diagnostic Techniques, Cardiovascular, Cardiovascular Agents/therapeutic use, Cardiovascular, Anoxia, Risk Factors, Biological Markers/blood, Hypoxia, Referral and Consultation, Heart Diseases/complications/diagnosis/therapy, media_common, Terminal Care, ddc:618, Exercise Tolerance, Pulmonary, Prognosis, Terminal Care/methods, Thromboembolism/complications/diagnosis/therapy, Hypertension, Cardiology, Cardiology and Cardiovascular Medicine, Algorithms, Lung Transplantation, medicine.medical_specialty, Hypertension, Pulmonary/*diagnosis/etiology/*therapy, Heart Diseases, media_common.quotation_subject, Hypertension, Pulmonary, MEDLINE, Pulmonary Veno-Occlusive Disease/complications/diagnosis/therapy, Internal medicine, Thromboembolism, Exercise Tolerance/physiology, medicine, Lung transplantation, Humans, Quality (business), Task force, business.industry, Conflict of interest, Cardiovascular Agents, Evidence-based medicine, Diagnostic Techniques, Clinical trial, Cardiovascular agent, Anoxia/complications/diagnosis/therapy, Pulmonary Veno-Occlusive Disease, business, Biomarkers
Abstract

Guidelines and Expert Consensus Documents summarize and evaluate all currently available evidence on a particular issue with the aim to assist physicians in selecting the best management strategies for a typical patient, suffering from a given condition, taking into account the impact on outcome, as well as the risk/benefit ratio of particular diagnostic or therapeutic means. Guidelines are no substitutes for textbooks. The legal implications of medical guidelines have been discussed previously. A great number of Guidelines and Expert Consensus Documents have been issued in recent years by the European Society of Cardiology (ESC) as well as by other societies and organizations. Because of the impact on clinical practice, quality criteria for development of guidelines have been established in order to make all decisions transparent to the user. The recommendations for formulating and issuing ESC Guidelines and Expert Consensus Documents can be found on the ESC website (http://www.escardio.org/knowledge/guidelines). In brief, experts in the field are selected and undertake a comprehensive review of the published evidence for management and/or prevention of a given condition. Unpublished clinical trial results are not taken into account. A critical evaluation of diagnostic and therapeutic procedures is performed including assessment of the risk/benefit ratio. Estimates of expected health outcomes for larger societies are included, where data exist. The level of evidence and the strength of recommendation of particular treatment options are weighed and graded according to predefined scales, as outlined in Tables 1 and 2 . View this table: Table 1 Classes of recommendations View this table: Table 2 Levels of evidence The experts of the writing panels have provided disclosure statements of all relationships they may have which might be perceived as real or potential sources of conflicts of interest. These disclosure forms are kept on file at the European Heart House, headquarters of the ESC. Any changes in conflict of interest that arise …

Published
2009

37. Is Xenotransplantation of Embryonic Stem Cells a Realistic Option?

Author

Michel Pucéat, Al Attar N, Michel Desnos, Alain Bel, Philippe Menasché, Pascal Pradeau, Laurent Sabbah, Patrick Bruneval, Le Deist F, Bellamy, Albert Hagège, Patrice Binder, Séverine Peyrard, Lionel Bonnevie, Weill B, and Claudine Menard

Subjects
Graft Rejection, Xenotransplantation, medicine.medical_treatment, CD3, Transplantation, Heterologous, Myocardial Infarction, T-Lymphocytes, Regulatory, Cell therapy, Electrocardiography, Mice, Ventricular Dysfunction, Left, Immune privilege, medicine, Animals, Embryonic Stem Cells, Transplantation, biology, business.industry, Embryonic stem cell, CD56 Antigen, Killer Cells, Natural, embryonic structures, Immunology, biology.protein, Stem cell, business, Immunostaining, Papio
Abstract

To test the purported immune privilege of embryonic stem cells (ESC) in the challenging setting of xenotransplantation, 14 immunocompetent baboons were subjected to a coronary artery occlusion-reperfusion sequence and, two weeks later, randomized to receive in-scar injections of culture medium or cardiac-committed mouse ESC engineered to express fluorescent reporter genes driven by cardiac-specific promoters. Two months after transplantation, left ventricular function, as assessed by echocardiography, deteriorated to a similar extent in control and treated baboons. This correlated with failure to identify the grafted cells by X-gal histology and immunofluorescence. Rejection did not seem to be mediated by xenoantibodies, but rather by T lymphocytes and natural killer cells as suggested by positive immunostaining for CD3 and CD56 early after transplantation. There was no increase in circulating levels of regulatory T cells. These data raise a cautionary note about the immune privilege of ESC and suggest that from a mere immunologic standpoint, ESC xenotransplantation is likely to be an unrealistic challenge.

Published
2007

46. Actualización de las guías de la Sociedad Europea de Cardiología (ESC) para el manejo de la fibrilación auricular de 2010 Elaborada en colaboración con la Asociación Europea del Ritmo Cardiaco

Author

Camm, Aj, Lip, Gy, Caterina, Rd, Savelieva, I, Atar, D, Hohnloser, Sh, Hindricks, G, Kirchhof, P, Bax, Jj, Baumgartner, H, Ceconi, C, Dean, V, Deaton, C, Fagard, R, Funck Brentano, C, Hasdai, D, Hoes, A, Knuuti, J, Kolh, P, Mcdonagh, T, Moulin, C, Popescu, Ba, Reiner, Z, Sechtem, U, Anton Sirnes, P, Tendera, M, Torbicki, A, Vahanian, A, Windecker, S, Vardas, P, Al Attar, N, Alfieri, O, Angelini, Annalisa, Blömstrom Lundqvist, C, Colonna, P, De Sutter, J, Ernst, S, Goette, A, Gorenek, B, Hatala, R, Heidbüchel, H, Heldal, M, Dalby Kristensen, S, Le Heuzey JY, Mavrakis, H, Mont, L, Perrone Filardi, P, Ponikowski, P, Prendergast, B, Rutten, Fh, Schotten, U, Van Gelder IC, Verheugt, Fw, Autores/miembros del Grupo de Trabajo, Comité de la ESC de Guías para la Práctica Clínica, and Revisores del documento

Published
2013

47. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation

Author

Camm, A.J., Lip, G.Y.H., Caterina, R. de, Savelieva, I., Atar, D., Hohnloser, S.H., Hindricks, G., Kirchhof, P., Bax, J.J., Baumgartner, H., Ceconi, C., Dean, V., Deaton, C., Fagard, R., Funck-Brentano, C., Hasdai, D., Hoes, A., Knuuti, J., Kolh, P., McDonagh, T., Moulin, C., Popescu, B.A., Reiner, Z., Sechtem, U., Sirnes, P.A., Tendera, M., Torbicki, A., Vahanian, A., Windecker, S., Vardas, P., Al-Attar, N., Alfieri, O., Angelini, A., Blomstrom-Lundqvist, C., Colonna, P., Sutter, J. de, Ernst, S., Goette, A., Gorenek, B., Hatala, R., Heidbuchel, H., Heldal, M., Kristensen, S.D., Heuzey, J.Y. le, Mavrakis, H., Mont, L., Filardi, P.P., Ponikowski, P., Prendergast, B., Rutten, F.H., Schotten, U., Gelder, I.C. van, Verheugt, F.W.A., Authors Task Force Members, and ESC Comm Practice Guidelines

Subjects
Focused update, Rate control, Guidelines, Upstream therapy, Left atrial appendage occlusion, Atrial fibrillation, Pulmonary vein isolation, Left atrial ablation, European Society of Cardiology, Antiarrhythmic drugs, Cardioversion, Anticoagulation, Rhythm control, Novel oral anticoagulants
Published
2012

48. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation * Developed with the special contribution of the European Heart Rhythm Association

Author

Camm, A.J., Lip, G.Y., Caterina, R. de, Savelieva, I., Atar, D., Hohnloser, S.H., Hindricks, G., Kirchhof, P., Bax, J.J., Baumgartner, H., Ceconi, C., Dean, V., Deaton, C., Fagard, R., Funck-Brentano, C., Hasdai, D., Hoes, A., Knuuti, J., Kolh, P., McDonagh, T., Moulin, C., Popescu, B.A., Reiner, Z., Sechtem, U., Sirnes, P.A., Tendera, M., Torbicki, A., Vahanian, A., Windecker, S., Vardas, P., Al-Attar, N., Alfieri, O., Angelini, A., Blomstrom-Lundqvist, C., Colonna, P., De Sutter, J., Ernst, S., Goette, A., Gorenek, B., Hatala, R., Heidbuchel, H., Heldal, M., Kristensen, S.D., Le Heuzey, J.Y., Mavrakis, H., Mont, L., Filardi, P.P., Ponikowski, P., Prendergast, B., Rutten, F.H., Schotten, U., Van Gelder, I.C., and Verheugt, F.W.A.

Subjects
Cardiovascular diseases [NCEBP 14]
Abstract

Item does not contain fulltext

Published
2012

49. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)

Author

Regitz Zagrosek, V, Blomstrom Lundqvist, C, Borghi, C, Cifkova, R, Ferreira, R, Foidart, Jm, Gibbs, Js, Gohlke Baerwolf, C, Gorenek, B, Iung, B, Kirby, M, Maas, Ah, Morais, J, Nihoyannopoulos, P, Pieper, Pg, Presbitero, P, Roos Hesselink JW, Schaufelberger, M, Seeland, U, Torracca, L, ESC Committee for Practice Guidelines, Bax, J, Auricchio, A, Baumgartner, H, Ceconi, Claudio, Dean, V, Deaton, C, Fagard, R, Funck Brentano, C, Hasdai, D, Hoes, A, Knuuti, J, Kolh, P, Mcdonagh, T, Moulin, C, Poldermans, D, Popescu, Ba, Reiner, Z, Sechtem, U, Sirnes, Pa, Torbicki, A, Vahanian, A, Windecker, S, Document, Reviewers, Aguiar, C, Al Attar, N, Garcia, Aa, Antoniou, A, Coman, I, Elkayam, U, Gomez Sanchez MA, Gotcheva, N, Hilfiker Kleiner, D, Kiss, Rg, Kitsiou, A, Konings, Kt, Lip, Gy, Manolis, A, Mebaaza, A, Mintale, I, Morice, Mc, Mulder, Bj, Pasquet, A, Price, S, Priori, Sg, Salvador, Mj, Shotan, A, Silversides, Ck, Skouby, So, Stein, Ji, Tornos, P, Vejlstrup, N, Walker, F, Warnes, C., ACS - Amsterdam Cardiovascular Sciences, and Cardiology

Subjects
Counseling, medicine.medical_specialty, Peripartum cardiomyopathy, Heart disease, Heart Diseases, Pregnancy Complications, Cardiovascular, Aortic Diseases, Coronary artery disease, Pregnancy, Internal medicine, Prenatal Diagnosis, Medicine, Humans, cardiovascular diseases, Pregnancy Complications, Infectious, Framingham Risk Score, business.industry, Contraindications, valvular heart disease, Atrial fibrillation, Abortion, Induced, Cardiovascular Agents, Prenatal Care, Venous Thromboembolism, medicine.disease, Heart failure, Cardiovascular agent, Hypertension, Cardiology, Female, Cardiology and Cardiovascular Medicine, business
Abstract

Table 1. Classes of recommendation Table 2. Levels of evidence Table 3. Estimated fetal and maternal effective doses for various diagnostic and interventional radiology procedures Table 4. Predictors of maternal cardiovascular events and risk score from the CARPREG study Table 5. Predictors of maternal cardiovascular events identified in congential heart diseases in the ZAHARA and Khairy study Table 6. Modified WHO classification of maternal cardiovascular risk: principles Table 7. Modified WHO classification of maternal cardiovascular risk: application Table 8. Maternal predictors of neonatal events in women with heart disease Table 9. General recommendations Table 10. Recommendations for the management of congenital heart disease Table 11. Recommendations for the management of aortic disease Table 12. Recommendations for the management of valvular heart disease Table 13. Recommendations for the management of coronary artery disease Table 14. Recommendations for the management of cardiomyopathies and heart failure Table 15. Recommendations for the management of arrhythmias Table 16. Recommendations for the management of hypertension Table 17. Check list for risk factors for venous thrombo-embolism Table 18. Prevalence of congenital thrombophilia and the associated risk of venous thrombo-embolism during pregnancy Table 19. Risk groups according to risk factors: definition and preventive measures Table 20. Recommendations for the prevention and management of venous thrombo-embolism in pregnancy and puerperium Table 21. Recommendations for drug use ABPM : ambulatory blood pressure monitoring ACC : American College of Cardiology ACE : angiotensin-converting enzyme ACS : acute coronary syndrome AF : atrial fibrillation AHA : American Heart Association aPTT : activated partial thromboplastin time ARB : angiotensin receptor blocker AS : aortic stenosis ASD : atrial septal defect AV : atrioventricular AVSD : atrioventricular septal defect BMI : body mass index BNP : B-type natriuretic peptide BP : blood pressure CDC : Centers for Disease Control CHADS : congestive heart failure, hypertension, age (>75 years), diabetes, stroke CI : confidence interval CO : cardiac output CoA : coarction of the aorta CT : computed tomography CVD : cardiovascular disease DBP : diastolic blood pressure DCM : dilated cardiomyopathy DVT : deep venous thrombosis ECG : electrocardiogram EF : ejection fraction ESC : European Society of Cardiology ESH : European Society of Hypertension ESICM : European Society of Intensive Care Medicine FDA : Food and Drug Administration HCM : hypertrophic cardiomyopathy ICD : implantable cardioverter-defibrillator INR : international normalized ratio i.v. : intravenous LMWH : low molecular weight heparin LV : left ventricular LVEF : left ventricular ejection fraction LVOTO : left ventricular outflow tract obstruction MRI : magnetic resonance imaging MS : mitral stenosis NT-proBNP : N-terminal pro B-type natriuretic peptide NYHA : New York Heart Association OAC : oral anticoagulant PAH : pulmonary arterial hypertension PAP : pulmonary artery pressure PCI : percutaneous coronary intervention PPCM : peripartum cardiomyopathy PS : pulmonary valve stenosis RV : right ventricular SBP : systolic blood pressure SVT : supraventricular tachycardia TGA : complete transposition of the great arteries TR : tricuspid regurgitation UFH : unfractionated heparin VSD : ventricular septal defect VT : ventricular tachycardia VTE : venous thrombo-embolism WHO : World Health Organization Guidelines summarize and evaluate all available evidence, at the time of the writing process, on a particular issue with the aim of assisting physicians in selecting the best management strategies for an individual patient, with a given condition, taking into account the impact on outcome, as well as the risk–benefit ratio of particular diagnostic or therapeutic means. Guidelines are no substitutes but are complements for textbooks and cover the European Society of Cardiology (ESC) Core Curriculum topics. Guidelines and recommendations should help the …

Published
2011

Catalog

Books, media, physical & digital resources
See catalog results